4//SEC Filing
Hooper Suzanne Sawochka 4
Accession 0001209191-19-030719
CIK 0001426332other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 11:45 AM ET
Size
8.5 KB
Accession
0001209191-19-030719
Insider Transaction Report
Form 4
Hooper Suzanne Sawochka
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-05-15+38,000→ 38,000 totalExercise: $13.35Exp: 2029-05-14→ Common Stock (38,000 underlying) - Award
Stock Option (Right to Buy)
2019-05-15+24,000→ 24,000 totalExercise: $13.35Exp: 2019-05-14→ Common Stock (24,000 underlying)
Footnotes (3)
- [F1]Issued pursuant to the Amended and Restated 2018 Equity Incentive Plan.
- [F2]The stock option shall vest over a three-year period, with 1/3rd of the shares vesting on August 10, 2019, and the remainder vesting in eight (8) equal quarterly installments thereafter, such that the option shall be fully vested on August 10, 2021, subject to the Reporting Person's Continuous Service (as defined in the Amended and Restated 2018 Equity Incentive Plan) on each applicable vesting date.
- [F3]The stock option shall vest in four (4) approximately equal quarterly installments, such that the option shall be fully vested on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day prior to the next Issuer's annual stockholder meeting held after the effective date of the initial public offering, subject to the Reporting Person's Continuous Service (as defined in the Amended and Restated 2018 Equity Incentive Plan) on each applicable vesting date.
Documents
Issuer
NGM BIOPHARMACEUTICALS INC
CIK 0001426332
Entity typeother
Related Parties
1- filerCIK 0001544589
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 11:45 AM ET
- Size
- 8.5 KB